These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32562342)

  • 1. Co-microencapsulation of human umbilical cord-derived mesenchymal stem and pancreatic islet-derived insulin producing cells in experimental type 1 diabetes.
    Montanucci P; Pescara T; Greco A; Leonardi G; Marini L; Basta G; Calafiore R
    Diabetes Metab Res Rev; 2021 Feb; 37(2):e3372. PubMed ID: 32562342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission of hyperglycemia in spontaneously diabetic NOD mice upon transplant of microencapsulated human umbilical cord Wharton jelly-derived mesenchymal stem cells (hUCMS).
    Montanucci P; Pescara T; Alunno A; Bistoni O; Basta G; Calafiore R
    Xenotransplantation; 2019 Mar; 26(2):e12476. PubMed ID: 30552781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of t cell substes of patients with type 1 diabetes mellitus by microencapsulated human umbilical cord Wharton jelly-derived mesenchymal stem cells: An in vitro study.
    Montanucci P; Alunno A; Basta G; Bistoni O; Pescara T; Caterbi S; Pennoni I; Bini V; Gerli R; Calafiore R
    Clin Immunol; 2016 Feb; 163():34-41. PubMed ID: 26680606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice.
    Wang HS; Shyu JF; Shen WS; Hsu HC; Chi TC; Chen CP; Huang SW; Shyr YM; Tang KT; Chen TH
    Cell Transplant; 2011; 20(3):455-66. PubMed ID: 20719086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-transplantation of mesenchymal stromal cells and cord blood cells in treatment of diabetes.
    Xiao N; Zhao X; Luo P; Guo J; Zhao Q; Lu G; Cheng L
    Cytotherapy; 2013 Nov; 15(11):1374-84. PubMed ID: 24094489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
    Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
    Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic insulin-producing cells differentiated from human embryonic stem cells correct hyperglycemia in SCID/NOD mice, an animal model of diabetes.
    Hua XF; Wang YW; Tang YX; Yu SQ; Jin SH; Meng XM; Li HF; Liu FJ; Sun Q; Wang HY; Li JY
    PLoS One; 2014; 9(7):e102198. PubMed ID: 25009980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
    Sharma A; Rani R
    Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCELL Expression on Murine MSC Licenses Pancreatotropism and Confers Durable Reversal of Autoimmune Diabetes in NOD Mice.
    Abdi R; Moore R; Sakai S; Donnelly CB; Mounayar M; Sackstein R
    Stem Cells; 2015 May; 33(5):1523-31. PubMed ID: 25641589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevascularized Retrievable Hybrid Implant to Enhance Function of Subcutaneous Encapsulated Islets.
    Mridha AR; Dargaville TR; Dalton PD; Carroll L; Morris MB; Vaithilingam V; Tuch BE
    Tissue Eng Part A; 2022 Mar; 28(5-6):212-224. PubMed ID: 33081600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microencapsulated Wharton Jelly-derived adult mesenchymal stem cells as a potential new therapeutic tool for patients with COVID-19 disease: an in vitro study.
    Montanucci P; Pescara T; Greco A; Francisci D; Basta G; Calafiore R
    Am J Stem Cells; 2021; 10(3):36-52. PubMed ID: 34552816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro immunomodulatory effects of microencapsulated umbilical cord Wharton jelly-derived mesenchymal stem cells in primary Sjögren's syndrome.
    Alunno A; Montanucci P; Bistoni O; Basta G; Caterbi S; Pescara T; Pennoni I; Bini V; Bartoloni E; Gerli R; Calafiore R
    Rheumatology (Oxford); 2015 Jan; 54(1):163-8. PubMed ID: 25065014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice.
    Dao LT; Park EY; Lim SM; Choi YS; Jung HS; Jun HS
    Transplantation; 2014 Nov; 98(10):1040-7. PubMed ID: 25208321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durable Control of Autoimmune Diabetes in Mice Achieved by Intraperitoneal Transplantation of "Neo-Islets," Three-Dimensional Aggregates of Allogeneic Islet and "Mesenchymal Stem Cells".
    Westenfelder C; Gooch A; Hu Z; Ahlstrom J; Zhang P
    Stem Cells Transl Med; 2017 Jul; 6(7):1631-1643. PubMed ID: 28467694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes.
    Chao KC; Chao KF; Fu YS; Liu SH
    PLoS One; 2008 Jan; 3(1):e1451. PubMed ID: 18197261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new immunodeficient hyperglycaemic mouse model based on the Ins2Akita mutation for analyses of human islet and beta stem and progenitor cell function.
    Pearson T; Shultz LD; Lief J; Burzenski L; Gott B; Chase T; Foreman O; Rossini AA; Bottino R; Trucco M; Greiner DL
    Diabetologia; 2008 Aug; 51(8):1449-56. PubMed ID: 18563383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet remodeling in female mice with spontaneous autoimmune and streptozotocin-induced diabetes.
    Plesner A; Ten Holder JT; Verchere CB
    PLoS One; 2014; 9(8):e102843. PubMed ID: 25101835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hTIMP-1 overexpression in human umbilical cord mesenchymal stem cells on the repair of pancreatic islets in type-1 diabetic mice.
    Bao Y; Zhao Z; Gao H
    Cell Biol Int; 2021 May; 45(5):1038-1049. PubMed ID: 33404139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.
    Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F
    Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.